title: Tazarotene--a topical retinoid for psoriasis.
abstract: Retinoids have been given systemically for severe psoriasis for several years. Tazarotene (Zorac-Allergan), the first retinoid to be marketed as a topical preparation for psoriasis, was recently licensed for mild-to-moderate plaque psoriasis involving up to 10% of the body surface area. Here we assess its place in the management of psoriasis.
mesh_terms: D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005782:Gels; D006801:Humans; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D012176:Retinoids / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D005782:Gels; D009539:Nicotinic Acids; D011355:Prodrugs; D012176:Retinoids; C086827:tazarotene